HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuai Ming Selected Research

Adalimumab (Humira)

1/2018Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuai Ming Research Topics

Disease

1Dacryocystitis (Dacryoadenitis)
03/2024
1Neoplasms (Cancer)
01/2024
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2024
1Glaucoma
06/2023
1Ocular Hypertension (Glaucoma, Suspect)
01/2022
1Ganglion Cysts (Ganglion)
01/2021
1Retinal Vein Occlusion
01/2020
1Uveitis
01/2018
1Inflammation (Inflammations)
01/2018
1HIV Seropositivity
01/2013

Drug/Important Bio-Agent (IBA)

1diquafosolIBA
06/2023
1Antiglaucoma AgentsIBA
01/2022
1Retinaldehyde (Retinal)IBA
01/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020
1Adalimumab (Humira)FDA Link
01/2018
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018

Therapy/Procedure

1Dacryocystorhinostomy
03/2024
1Therapeutics
01/2024
1Aftercare (After-Treatment)
01/2022
1Condoms (Condom)
01/2013